Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2010078935) SOLUTIONS FOR VOLUME THERAPY
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/078935 International Application No.: PCT/EP2009/009123
Publication Date: 15.07.2010 International Filing Date: 18.12.2009
Chapter 2 Demand Filed: 22.12.2010
IPC:
A61K 9/08 (2006.01) ,A61P 7/08 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
08
Solutions
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
7
Drugs for disorders of the blood or the extracellular fluid
08
Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Applicants:
FRESENIUS KABI DEUTSCHLAND GMBH [DE/DE]; Else-Kröner-Strasse 1 63152 Bad Homburg, DE (AllExceptUS)
BREITER, Norbert [DE/DE]; DE (UsOnly)
Inventors:
BREITER, Norbert; DE
Agent:
RICHLY, Erik; Fresenius Kabi Deutschland GmbH Patent Department Else-Kröner-Strasse 1 61352 Bad Homburg, DE
Priority Data:
08022089.019.12.2008EP
Title (EN) SOLUTIONS FOR VOLUME THERAPY
(FR) SOLUTIONS POUR THÉRAPIE DE VOLUME
Abstract:
(EN) The invention relates to artificial plasma-like solutions and methods for their use. The subject solutions find use in a variety of applications, particularly in those applications where at least a portion of a host's blood volume is replaced with a blood substitute.
(FR) L'invention concerne des solutions de type plasma artificiel et des procédés pour leur utilisation. Les présentes solutions trouvent une utilité dans une pluralité d'applications, en particulier dans les applications où au moins une partie du volume de sang d'un hôte est remplacée par un substitut sanguin.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP2367530US20110257090CN102256593CA2747680AU2009336790IN4389/DELNP/2011